| Filed | Form | Description | |
|---|---|---|---|
| 4/24/25 | DEFA14A | DEFA14A | → |
| 4/24/25 | DEF 14A | DEF 14A | → |
| 4/24/24 | DEF 14A | DEF 14A | → |
| 4/24/24 | DEFA14A | DEFA14A | → |
| 4/24/23 | DEFA14A | DEFA14A | → |
| 4/24/23 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/2/26 | 4 | 4 | → |
| 2/27/26 | 4 | 4 | → |
| ↓ | |||
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.